Target intelligence / Profile preview

Ketol-acid reductoisomerase (KARI)

Target
KARI
Molecular classification
Enzyme, Oxidoreductase
01

Overview

Ketol-acid reductoisomerase (KARI) is a magnesium-dependent, NADPH-utilizing bifunctional enzyme that catalyzes two sequential reactions in the biosynthesis of branched-chain amino acids (valine, leucine, and isoleucine) in bacteria, plants, and fungi but not in animals[1][2][3][4][5]. It orchestrates an alkyl migration (isomerization) followed by a reductive step using NADPH[2][3]. There are two main KARI classes: the short form, found in fungi and many bacteria, and the long form, found in plants and some bacteria[1][2]. The enzyme is essential for growth and survival in organisms that rely on de novo synthesis of branched-chain amino acids[4]. KARI is the target of several herbicides and is under investigation as a potential antibacterial and antifungal target given its absence in animal metabolism[4][7][8]. Structurally, KARI forms oligomeric assemblies (dimers, tetramers, or dodecamers) and relies on conserved residues to coordinate metal ions and catalyze the reaction[1][3]. Inactivation of KARI disrupts branched-chain amino acid synthesis, leading to growth arrest in sensitive organisms[4]. KARI’s unique role in non-animal organisms makes it an attractive target in agriculture and anti-infective research.

Other names
Ketol-acid reductoisomerase (NADP(+))Keto-acid reductoisomeraseILVC (especially in fungal literature)EC 1.1.1.86
02

Mechanism of action

Competitive inhibition of substrate binding or cofactor (NADPH or Mg2+) binding; Disruption of branched-chain amino acid biosynthesis, leading to amino acid starvation

03

Biological functions

Biosynthesis of branched-chain amino acids (valine, leucine, isoleucine)Amino acid metabolism
04

Disease associations

Infection (as an antibacterial, antifungal, and herbicidal target since it's essential in non-animals)Other (essential metabolic enzyme in bacteria, fungi, and plants, but not animals)
05

Safety considerations

Low toxicity concern to humans (enzyme absent in animals)Possible development of resistance in target organisms (plants, bacteria, fungi)Off-target impact on non-target plants or microbes in environmental/agricultural context
06

Interacting drugs

Sulfonylurea and imidazolinone herbicides (e.g., sulfometuron-methyl, imazapyr; used in plants, experimental inhibitors in bacteria/fungi)
07

Biomarkers

null (no validated clinical biomarkers for patient selection; possible use as a marker of enzyme activity in microbial or plant studies, but none in clinical practice)

Beyond the preview

Go deeper on Ketol-acid reductoisomerase (KARI).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ketol-acid reductoisomerase (KARI).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call